ASCEND BY NTHRYS
Research Abroad Products

Proteomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 13–24 of 200 project topics
Real-Time Cancer Liquid Biopsy Proteomics Testing Platform
Clinical-grade SaaS platform enabling non-invasive cancer detection and monitoring through circulating protein signatures in blood samples. Captures recurring B2B revenue from oncology clinics and hospital networks while establishing market position in precision diagnostics.
Cancer Proteomics Drug Discovery Platforms Click to view more details →
Therapeutic Resistance Profiling Software for Drug Optimization
Cloud-based analytical tool that maps protein expression signatures associated with chemotherapy and immunotherapy resistance in tumor samples. Generates licensing revenue while helping pharmaceutical firms design combination therapies and overcome resistance mechanisms.
Cancer Proteomics Drug Discovery Platforms Click to view more details →
Multi-Omics Integration Platform for Immuno-Oncology Targets
Enterprise SaaS solution integrating proteomics, genomics, and transcriptomics data to identify novel checkpoint inhibitor targets and patient response predictors. Monetizes through annual subscriptions to biotech and pharma companies seeking competitive advantage in immunotherapy development.
Cancer Proteomics Drug Discovery Platforms Click to view more details →
Phosphoproteomics Signaling Pathway Analysis Commercial Service
Specialized laboratory and bioinformatics service analyzing phosphorylation states to map dysregulated kinase signaling in cancer cells. Drives revenue through service contracts while enabling clients to identify and prioritize kinase inhibitor development candidates.
Cancer Proteomics Drug Discovery Platforms Click to view more details →
Patient-Derived Xenograft Protein Profiling Data Platform
Proprietary database and analytics tool aggregating proteomics data from thousands of patient-derived xenograft models for drug response prediction. Monetizes through tiered access licensing while enabling pharmaceutical partners to predict clinical efficacy before human trials.
Cancer Proteomics Drug Discovery Platforms Click to view more details →
Spatial Proteomics Tumor Microenvironment Mapping Software
Advanced imaging software platform that spatially maps protein expression in tumor tissues to reveal immune infiltration and stromal interactions. Generates revenue through software licenses and professional services while helping clients optimize combination immunotherapy strategies.
Cancer Proteomics Drug Discovery Platforms Click to view more details →
Protein-Drug Interaction Screening Platform for Cancer Therapeutics
High-throughput commercial platform screening thousands of candidate compounds against cancer target proteins using thermal proteomics technologies. Captures revenue through screening contracts and hit-to-lead optimization services while accelerating early-stage pipeline advancement.
Cancer Proteomics Drug Discovery Platforms Click to view more details →
Tumor Microenvironment Cell Type Deconvolution Analytics Service
Computational service using proteomics signatures to deconvolve and quantify immune and stromal cell populations within bulk tumor samples. Monetizes through per-sample analysis fees while enabling clients to assess tumor immunogenicity and predict checkpoint inhibitor response.
Cancer Proteomics Drug Discovery Platforms Click to view more details →
SRM/MRM Assay Development Platform for Biomarker Discovery
A cloud-based SaaS platform that automates the design and optimization of Selected Reaction Monitoring (SRM) and Multiple Reaction Monitoring (MRM) assays for rapid biomarker validation. This service reduces assay development time from months to weeks, enabling laboratories to monetize biomarker discovery through faster clinical translation and companion diagnostic development.
Targeted Proteomics Assay Service Development Click to view more details →
High-Throughput Multiplexed Protein Quantification Service
A commercial laboratory service that performs simultaneous quantification of 50-500 proteins per sample using parallel reaction monitoring (PRM) or data-independent acquisition (DIA) techniques. This service generates recurring revenue through per-sample analysis fees while enabling pharmaceutical and biotech clients to accelerate drug development and biomarker-driven study designs.
Targeted Proteomics Assay Service Development Click to view more details →
Peptide Standard Reference Library Management Software
An integrated software platform and repository service that manages, catalogs, and distributes stable isotope-labeled peptide standards for targeted proteomics assays with full traceability and quality control documentation. The platform creates a B2B SaaS revenue model through subscription tiers, per-peptide licensing, and premium custom synthesis services.
Targeted Proteomics Assay Service Development Click to view more details →
Clinical Sample Proteomics Biomarker Validation Service
A CLIA-certified service laboratory offering targeted proteomics analysis of clinical samples (serum, plasma, tissue) for biomarker validation and clinical utility studies using validated targeted assays. This service addresses the diagnostic and companion diagnostic market, generating revenue through per-sample analysis, assay development contracts, and licensing opportunities to diagnostic companies.
Targeted Proteomics Assay Service Development Click to view more details →